Imiquimod-induced skin inflammation is partially reduced in mice deficient for both IL-1α/IL-1β or for IL-1R1, but not in IL-1α- or IL-1β-deficient mice, demonstrating the redundant activity of IL-1α and IL-1β for skin inflammation (156). The gene discussed is IL1B; the disease is dermatitis.